The AMDI Respiratory Panel tests for the 4 most probable viruses that cause respiratory tract infections since the pandemic, including influenza A and B, respiratory syncytial virus and SARS-CoV-2.
A compact, easy to use molecular point-of-care system that utilizes multiplexing capability specifically for CLIA-waived environments.
It can run up to 32 targets at a time on a single sample in <10 minutes using a disposable disc.
The AMDI Fast PCR system is designed to be:
Simple and intuitive sample to answer workflow that takes <10 minutes
<10 MINUTE SAMPLE TO ANSWER 32 PLEX RT-PCR
1 RT-PCR TEST. 4 TARGETS. <10 MINUTES
AMDI RESPIRATORY PANEL
AMDI is developing targeted syndromic panels for the point-of-care using both the AMDI HBH technology and the gold-standard lab-quality RT-PCR technique.
AMDI Respiratory Panel
Sample Type: Anterior Nasal Swab in 1-3 mL Viral Transport Media
AMDI HBH Technology
AMDI has patented HBH Technology that eliminates the lengthy sample prep process in many RT-PCR workflows:
- 15 seconds
- Optimized Reagents
- Small Volumes (no dilutions needed)
- Comparable Sensitivity to the Gold Standard
Targets Assayed Using Hyperbaric Heating Technology:
Virus (SARS-CoV-2, Flu A/B, RSV, etc.), Bacteria (Bacillus), Eukaryotes (S. cerevisiae, HeLa) and Fungus (Candida)
